FDA Slams Stem-Cell Bad Actors, Announces New Regulatory Framework

Drug Industry Daily
A A
FDA Commissioner Scott Gottlieb announced moves to crack down on illicit marketers of stem-cell therapies while also pledging to foster ethical innovation in the field.

To View This Article:

Login

Subscribe To Drug Industry Daily